Our partner NOVAPTECH participated in BioFIT 2025, held in Strasbourg, one of Europe’s leading events dedicated to life-science partnering and innovation.
During the event, the NOVAPTECH team presented their latest NOVAptamers, showcasing results from the 2D-BioPAD project. These innovative aptamers are designed to detect a wide range of targets, including small molecules such as fungicides and antibiotics, as well as proteins like NFL, GFAP, hemagglutinin, and influenza neuraminidase. The results highlighted the versatility and performance of NOVAPTECH’s aptamer technologies across multiple application areas.
NOVAPTECH also demonstrated the potential of their NOVAswitch technology, which enables faster and more efficient diagnostic, research, and development workflows.
We congratulate the NOVAPTECH team on their successful participation in BioFIT 2025 and their continued contribution to advancing life-science detection and diagnostic solutions.
